Boeing Company (The) (BA)

Executive Summary

Boeing shares extended their losing streak for a fifth consecutive reporting period, declining 2.00% from $212.07 to $207.82 since the July 17 report, bringing the cumulative drawdown from the July 10 high of $226.42 to approximately 8.2%. While management announced new aircraft orders with MSC Air Cargo, Uganda Airlines, and Luxair at the Farnborough Airshow and reaffirmed expectations for positive cash flow in the second half of 2026, CEO Kelly Ortberg’s explicit guidance that Boeing requires "a couple more years" to repair its balance sheet before launching a new jet program reinforces that near-term upside remains constrained by financial stabilization priorities.

Current Trend

The stock remains in a pronounced downtrend across all measured timeframes: YTD -4.28%, 1-month -6.69%, and 6-month -16.89%. The 5-day performance of -4.28% marks an acceleration of selling pressure relative to the prior period. Since July 10, the equity has shed roughly $18.60 per share in a near-linear descent, with previously identified support near $212 and $216 now breached and converted to overhead resistance. The current price of $207.82 establishes a new lower bound within this sequence; a sustained recovery would require reclamation of the $212–$216 zone, while failure to hold current levels risks further downside extension.

Investment Thesis

The core thesis remains a multi-year operational turnaround predicated on production rate stabilization, certification of delayed variants, and balance sheet repair. Company-specific catalysts include the expansion of 737 MAX output to a second Everett line with a target of 52 jets per month, first-half deliveries of 314 aircraft representing the strongest period since 2018, and a backlog of roughly 6,200 to nearly 7,000 aircraft. Management has guided to cash flow positivity in H2 2026 and has secured new orders from MSC Air Cargo, Uganda Airlines, and Luxair at Farnborough. Offsetting these positives, the commercial unit is not expected to generate consistent near-term profits due in part to a $1 billion investment in the Everett expansion, and the CEO has deferred any new clean-sheet aircraft program until approximately 2030, indicating that transformative revenue growth is unlikely this decade.

Thesis Status

The thesis is unchanged in directional intent but the timeline for fundamental recovery has been further clarified—and extended. The Farnborough order flow and production milestones support the bull narrative of operational normalization, yet the market is repricing the equity lower on management’s candid admission that financial repair and a new jet launch remain years away. The persistent price weakness suggests investors are discounting near-term execution risks and demanding evidence of sustained free cash flow generation before assigning a higher valuation. The thesis remains valid but is firmly in the "show me" phase.

Key Drivers

• Farnborough Airshow Order Activity: Boeing announced deals with MSC Air Cargo, Uganda Airlines, and Luxair, while positioning for additional orders from SMBC Aviation Capital, Philippine Airlines, Etihad Airways, and Ethiopian Airlines Group. Morningstar; Bloomberg

• Production Ramp and Capacity Expansion: The company opened a second 737 MAX production line in Everett, Washington, targeting an increase from the current FAA-cleared rate of 47 planes per month to 52 and beyond. The New York Times

• Financial Stabilization Guidance: CEO Kelly Ortberg stated the company expects to be cash flow positive in the second half of 2026 but requires "a couple more years" of financial repair before funding a new commercial aircraft program, now targeted for readiness by 2030. CNBC; Financial Times

• Certification Milestones: The long-delayed 737 MAX 7, MAX 10, and 777-9 are nearing certification, with deliveries expected to begin next year, which is critical to unlocking backlog value. The New York Times

• Quality Metrics: Defect-related labor time on the 737 line has declined by nearly 20% and fuselage defects by 40%, supporting the production ramp thesis. The New York Times

Technical Analysis

Price action is decisively bearish in the near term. The 2.00% decline since the last report breaks the $212.07 prior low and confirms a series of lower highs and lower lows. Immediate resistance is now defined by the prior support cluster at $212–$216. The 5-day performance of -4.28% indicates accelerating momentum to the downside. YTD performance at -4.28% and 6-month performance at -16.89% demonstrate that the stock is underperforming broader market indices. No reversal pattern is evident; the trajectory remains downward until buyers reclaim the $212 level on a closing basis.

Bull Case

• Robust Backlog and Order Flow: The company maintains a backlog of roughly 6,200 to nearly 7,000 aircraft and announced new Farnborough deals with MSC Air Cargo, Uganda Airlines, and Luxair, providing multi-year revenue visibility. Morningstar; The New York Times
• Production Recovery and Delivery Momentum: Boeing delivered 314 jets in the first half of 2026, its best performance for that period since 2018, and 171 aircraft in Q2 alone, up 12% year-over-year. The New York Times; Financial Times
• Path to Positive Cash Flow: Management anticipates turning cash flow positive in the second half of 2026, a critical inflection point for balance sheet repair and creditor confidence. Financial Times
• Certification Catalysts: Pending certification of the 737 MAX 7, MAX 10, and 777-9 variants is expected to unlock deliveries beginning next year, broadening the revenue base. The New York Times
• Operational Quality Improvements: Measurable gains in manufacturing quality, including a ~20% reduction in defect-related labor time and a 40% reduction in fuselage defects, support the sustainability of the production rate increase. The New York Times

Bear Case

• Extended Timeline for New Program Launch: CEO Kelly Ortberg explicitly stated that Boeing will not be ready to fund a new aircraft program until around 2030, capping long-term growth aspirations and conceding the narrowbody innovation cycle to Airbus for the remainder of the decade. CNBC; Financial Times
• Persistent Near-Term Losses in Commercial Aviation: The commercial airplane unit is not expected to generate consistent profits in the near